NASDAQ: CDMO
3.81
+ 0.02 (+0.53%)
4:00 PM ET on Jan 12, 2018
Delayed at least 20 minutes.

Press Releases

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
Jan 5, 2018
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
Jan 2, 2018
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer
Dec 26, 2017

Upcoming Events

Annual Meeting of Stockholders
Jan 18, 2018 at 10:00 AM PT

Contacts

Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.

P.O. Box 1342
Brentwood, NY 11717
Toll-Free: 866-232-0395
International: 720-358-3630
shareholder@broadridge.com

Corporate Office

2642 Michelle Drive, Suite 200,
Tustin, CA 92780
Phone: 714-508-6000

Investor Relations/Corporate Communications

Stephanie Diaz

Vida Strategic Partners
Phone: 415-675-7401
Toll-Free: 800-987-8256
sdiaz@vidasp.com

Search Investor Relations